Eli Lilly and Company (NYSE: LLY) announced the completion of its acquisition of AtaiBeckley Inc., a clinical-stage biopharmaceutical company developing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE